Total Payments
$22,111
2024 Payments
$4,048
Companies
40
Transactions
1,356
Medicare Patients
15,005
Medicare Billing
$10.5M
Payment Breakdown by Category
Food & Beverage$21,700 (98.1%)
Education$410.61 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,700 | 1,345 | 98.1% |
| Education | $410.61 | 11 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,750 | 335 | $0 (2024) |
| UCB, Inc. | $1,974 | 123 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,901 | 117 | $0 (2024) |
| Amgen Inc. | $1,884 | 103 | $0 (2024) |
| PFIZER INC. | $1,373 | 95 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,311 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $1,090 | 57 | $0 (2024) |
| Genentech USA, Inc. | $889.76 | 68 | $0 (2024) |
| GENZYME CORPORATION | $787.41 | 51 | $0 (2024) |
| Lilly USA, LLC | $786.27 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,048 | 210 | ABBVIE INC. ($1,230) |
| 2023 | $3,900 | 214 | ABBVIE INC. ($1,234) |
| 2022 | $3,491 | 198 | ABBVIE INC. ($807.87) |
| 2021 | $2,177 | 144 | AbbVie Inc. ($611.18) |
| 2020 | $818.10 | 59 | AbbVie Inc. ($195.51) |
| 2019 | $2,438 | 165 | Novartis Pharmaceuticals Corporation ($359.03) |
| 2018 | $2,575 | 180 | Genentech USA, Inc. ($352.33) |
| 2017 | $2,663 | 186 | Celgene Corporation ($352.20) |
All Payment Transactions
1,356 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Immunology | ||||||
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $2.46 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: Immunology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/10/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Immunology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $21.34 | General |
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: INFLIXIMAB | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 3,808 | 193,018 | $7.1M | $2.3M |
| 2022 | 50 | 3,623 | 205,741 | $7.5M | $2.6M |
| 2021 | 50 | 3,917 | 207,990 | $7.9M | $3.0M |
| 2020 | 47 | 3,657 | 167,418 | $7.4M | $2.7M |
Total Patients
15,005
Total Services
774,167
Medicare Billing
$10.5M
Procedure Codes
192
All Medicare Procedures & Services
192 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 76 | 23,001 | $2.1M | $772,528 | 37.3% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 43 | 5,986 | $1.0M | $379,594 | 36.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 29 | 64,757 | $694,106 | $302,722 | 43.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 57 | 25,570 | $1.3M | $269,354 | 21.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 45 | 55,600 | $834,000 | $214,035 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 398 | 708 | $177,000 | $62,669 | 35.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 13 | 6,512 | $108,150 | $51,436 | 47.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 14 | 1,910 | $210,100 | $47,372 | 22.5% |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2023 | 12 | 1,551 | $192,200 | $44,507 | 23.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 107 | 270 | $135,000 | $25,115 | 18.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 1,200 | $51,480 | $21,462 | 41.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 158 | 461 | $59,930 | $21,299 | 35.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 423 | 875 | $26,250 | $9,030 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $22,720 | $8,376 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 119 | $20,825 | $7,199 | 34.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 402 | 856 | $21,400 | $6,499 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 415 | 775 | $9,300 | $6,476 | 69.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 71 | 253 | $37,950 | $5,178 | 13.6% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 335 | 687 | $12,366 | $3,480 | 28.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 328 | $11,480 | $3,471 | 30.2% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 76 | 152 | $8,758 | $3,367 | 38.4% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 80 | 216 | $9,720 | $2,540 | 26.1% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 37 | 38 | $5,700 | $2,308 | 40.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 68 | 75 | $7,125 | $2,176 | 30.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 49 | $8,575 | $2,066 | 24.1% |
About Dr. Brent Flickinger, MD
Dr. Brent Flickinger, MD is a Rheumatology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902914872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Flickinger, MD has received a total of $22,111 in payments from pharmaceutical and medical device companies, with $4,048 received in 2024. These payments were reported across 1,356 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($21,700).
As a Medicare-enrolled provider, Flickinger has provided services to 15,005 Medicare beneficiaries, totaling 774,167 services with total Medicare billing of $10.5M. Data is available for 4 years (2020–2023), covering 192 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Gainesville, GA
- Active Since 08/29/2006
- Last Updated 07/14/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902914872
Products in Payments
- RINVOQ (Biological) $2,850
- Cimzia (Drug) $1,841
- ORENCIA (Biological) $1,289
- Enbrel (Biological) $1,205
- COSENTYX (Biological) $1,107
- XELJANZ (Drug) $1,033
- SKYRIZI (Biological) $911.14
- COSENTYX (Drug) $794.65
- TREMFYA (Drug) $702.36
- KRYSTEXXA (Biological) $690.25
- SAPHNELO (Biological) $663.27
- Rituxan (Biological) $594.83
- Humira (Biological) $551.92
- TALTZ (Drug) $521.43
- KEVZARA (Drug) $499.14
- LUPKYNIS (Drug) $489.70
- BENLYSTA (Biological) $418.79
- OFEV (Drug) $396.33
- KRYSTEXXA (Drug) $327.05
- Actemra (Biological) $294.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Gainesville
N. Edwards, Md, MD
Rheumatology — Payments: $78,170
Rheumatology $78,170
Dina Hammad
Rheumatology — Payments: $61,680
Rheumatology $61,680
Ann Chauffe, Do, Mph, DO, MPH
Rheumatology — Payments: $57,166
Rheumatology $57,166
Marta Bognar, M.d, M.D
Rheumatology — Payments: $35,095
Rheumatology $35,095
Dr. William Chafin, M.d, M.D
Rheumatology — Payments: $26,601
Rheumatology $26,601
Michael Bubb, Md, MD
Rheumatology — Payments: $18,664
Rheumatology $18,664